Impact of Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) on AL Amyloidosis Outcomes

Autologous stem cell transplantation (ASCT) remains the preferred standard consolidation therapy for patients with AL amyloidosis. Whilst several factors are known to impact outcomes, conventional risk scores for transplant-related mortality such as the HCT-CI have not been fully explored in this setting.

https://www.astctjournal.org/article/S2666-6367(23)02279-0/fulltext?rss=yes

Source: Biology of Blood and Marrow Transplantation - February 1, 2024 Category: Hematology Authors: Portia Smallbone, Supawee Saengboon, Qaiser Bashir, Blessie Elizabeth Nelson, Jeremy Ramdial, Neeraj Y. Saini, Chitra Hosing, Uday R. Popat, Ruby Delgado, Melody Becnel, Hans C. Lee, Robert Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Q Tags: 533 Source Type: research